AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Extended-regimen OC measures up.(Gynecology)

OB GYN News

| June 15, 2006 | Splete, Heidi | COPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

WASHINGTON -- Seasonale Lo, the 91-day extended-regimen low-dose oral contraceptive, was effective and well tolerated compared with a 28-day low-dose oral contraceptive, after both 1 year and 3 years of use.

The Seasonale Lo data from a randomized, multicenter study were presented in two posters at the annual meeting of the American College of Obstetricians and Gynecologists.

Dr. Andrew M. Kaunitz of the University of Florida Health Science Center in Jacksonville, Fla., monitored women aged 18-35 years who could potentially become pregnant. After 1 year, the overall cumulative failure rate of Seasonale Lo was 2.23% among 463 patients, compared with a 2.83% failure rate among 231 patients who took a traditional 28-day oral contraceptive (Levlite).

Compliance rates were high--98.1% in the Seasonale Lo group and 96.5% in the Levlite group. Among compliant patients, the Seasonale Lo failure rate was only 0.65%, compared with 4.14% among compliant Levlite patients. Although more Seasonale patients reported unscheduled bleeding days than the Levlite patients (6.1% vs. 3.3%), the number of scheduled bleeding or spotting days per cycle was approximately the same in both groups.

Breakthrough bleeding episodes were reported more frequently by the Seasonale Lo group than the Levlite group (13.8% vs. 1.3%), but the incidence of other adverse events was similar between the two groups. For ...

Related articles from newspapers, magazines, journals, and more
Barr Pharmaceuticals Inc, a Company Analysis Including 16 Deals Made, and 21...
Press release article from: Business Wire November 7, 2005 700+ words
...has announced the addition of Barr Pharmaceuticals Inc Deals Briefing to their offering. Description Barr Pharmaceuticals Inc Deals briefing provides...view of the 16 deals made by Barr Pharmaceuticals Inc and its subsidiaries with...
Barr Pharmaceuticals Inc, a company analysis including 16 deals made, and 21...
Press release article from: M2 Presswire October 27, 2005 700+ words
...2005-Research and Markets: Barr Pharmaceuticals Inc, a company analysis including...announced the addition of Barr Pharmaceuticals Inc Deals Briefing to their offering Description Barr Pharmaceuticals Inc Deals briefing provides...
Trade Alert for Barr Pharmaceuticals Inc.
Press release article from: M2 Presswire May 10, 2007 700+ words
...May 2007-Biotech News: Trade Alert for Barr Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:10052007 Trade Alert for Barr Pharmaceuticals Inc (NYSE:BRL) Barr Pharmaceuticals, Inc. engages in the development, manufacture...
/C O R R E C T I O N -- Barr Pharmaceuticals, Inc. (NYSE: BRL)/.
Press release article from: PR Newswire August 21, 2008 700+ words
In the news release, Barr Pharmaceuticals, Inc. (NYSE: BRL...yesterday, Aug. 20, by Barr Pharmaceuticals, Inc. over PR Newswire...release changed to, "Barr Pharmaceuticals, Inc. (NYSE: BRL...
Barr Changes State of Incorporation to Delaware; Company changes Name to Barr...
Press release article from: PR Newswire January 2, 2004 700+ words
Barr Pharmaceuticals, Inc. today announced that...Barr Laboratories, Inc. into Barr Pharmaceuticals, Inc., which is incorporated...Company's corporate name became Barr Pharmaceuticals, Inc. As a result of the reincorporation...
Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review.
Press release article from: M2 Presswire May 6, 2009 700+ words
...companiesandmarkets.com: Barr Pharmaceuticals, Inc. - Financial and Strategic...companiesandmarkets.com adds new report: Barr Pharmaceuticals, Inc. - Financial and Strategic Analysis Review Barr Pharmaceuticals, Inc. - Financial and Strategic...
Barr Pharmaceuticals Inc. Review in Progress.
Press release article from: M2 Presswire March 28, 2008 700+ words
...March 2008-The Maybach Journal: Barr Pharmaceuticals Inc. Review in Progress(C)1994...March 28, 2008, we have added Barr Pharmaceuticals Inc. (NYSE:BRL) to the list...numerous publicly traded companies Barr Pharmaceuticals Inc. was up over $0.05 on below...
Progressive Following on Barr Pharmaceuticals Inc.
Press release article from: M2 Presswire March 28, 2008 700+ words
...Corner: Progressive Following on Barr Pharmaceuticals Inc.(C)1994-2008 M2 COMMUNICATIONS...resumed our progressive review of Barr Pharmaceuticals Inc. (NYSE:BRL) as it opened...various prospective companies therein Barr Pharmaceuticals Inc. was among those that we have...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA